Adverum Biotechnologies Stock Buy Hold or Sell Recommendation
| ADVM Stock | USD 6.88 0.24 3.61% |
Given the investment horizon of 90 days and your bold attitude towards risk, our recommendation regarding Adverum Biotechnologies is 'Strong Sell'. The recommendation algorithm takes into account all of Adverum Biotechnologies' available fundamental, technical, and predictive indicators you will find on this site.
Check out Adverum Biotechnologies Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide. Note, we conduct extensive research on individual companies such as Adverum and provide practical buy, sell, or hold advice based on investors' constraints. Adverum Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Adverum |
Execute Adverum Biotechnologies Buy or Sell Advice
The Adverum recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Adverum Biotechnologies. Macroaxis does not own or have any residual interests in Adverum Biotechnologies or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Adverum Biotechnologies' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Moderately volatile | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Adverum Biotechnologies Trading Alerts and Improvement Suggestions
| Adverum Biotechnologies had very high historical volatility over the last 90 days | |
| Adverum Biotechnologies has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 3.6 M. Net Loss for the year was (117.17 M) with loss before overhead, payroll, taxes, and interest of (81.68 M). | |
| Adverum Biotechnologies currently holds about 235.84 M in cash with (90.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.37. | |
| Adverum Biotechnologies has a frail financial position based on the latest SEC disclosures | |
| Over 79.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from investing.com: Mizuho cuts Adverum price target to 16, maintains outperform |
Adverum Biotechnologies Returns Distribution Density
The distribution of Adverum Biotechnologies' historical returns is an attempt to chart the uncertainty of Adverum Biotechnologies' future price movements. The chart of the probability distribution of Adverum Biotechnologies daily returns describes the distribution of returns around its average expected value. We use Adverum Biotechnologies price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Adverum Biotechnologies returns is essential to provide solid investment advice for Adverum Biotechnologies.
| Mean Return | 0.06 | Value At Risk | -6.81 | Potential Upside | 5.04 | Standard Deviation | 3.49 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Adverum Biotechnologies historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Adverum Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Adverum Biotechnologies, soars without any apparent reason. This usually happens because many institutional investors are aggressively trading Adverum Biotechnologies back and forth among themselves. Companies that invest excess capital in these types of assets may also be included in this term and can influence corporate governance by exercising voting rights in their investments.
| Shares | Logos Global Management Lp | 2024-09-30 | 416.7 K | State Street Corp | 2024-09-30 | 369.6 K | Pale Fire Capital Se | 2024-09-30 | 308.4 K | Soleus Capital Management, L.p. | 2024-09-30 | 287.2 K | Fmr Inc | 2024-09-30 | 234.7 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 206.7 K | Bank Of America Corp | 2024-06-30 | 176.1 K | Nuveen Asset Management, Llc | 2024-09-30 | 173.7 K | Northern Trust Corp | 2024-09-30 | 155 K | Bml Capital Management Llc | 2024-09-30 | 2.3 M | Tcg Crossover Management, Llc | 2024-09-30 | 2 M |
Adverum Biotechnologies Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (89.1M) | (3.5M) | (26.7M) | 34.2M | 6.0M | 5.1M | |
| Free Cash Flow | (68.4M) | (91.1M) | (123.0M) | (119.9M) | (91.7M) | (87.1M) | |
| Depreciation | 1.6M | 4.2M | 4.6M | 6.5M | 5.6M | 5.9M | |
| Other Non Cash Items | 58K | 75K | (25K) | (51K) | 11.4M | 11.9M | |
| Capital Expenditures | 19.2M | 11.8M | 15.1M | 11.8M | 808K | 767.6K | |
| Net Income | (64.5M) | (117.5M) | (145.5M) | (154.5M) | (117.2M) | (123.0M) | |
| End Period Cash Flow | 66.9M | 63.4M | 36.7M | 70.9M | 77.0M | 76.3M | |
| Investments | (48.8M) | (268.3M) | 93.8M | 141.7M | 96.9M | 101.7M | |
| Change To Netincome | 9.9M | 20.8M | 26.2M | 20.0M | 18.0M | 17.6M |
Adverum Biotechnologies Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Adverum Biotechnologies or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Adverum Biotechnologies' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Adverum stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.13 | |
β | Beta against Dow Jones | 1.59 | |
σ | Overall volatility | 3.53 | |
Ir | Information ratio | -0.02 |
Adverum Biotechnologies Volatility Alert
Adverum Biotechnologies shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Adverum Biotechnologies' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Adverum Biotechnologies' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Adverum Biotechnologies Fundamentals Vs Peers
Comparing Adverum Biotechnologies' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Adverum Biotechnologies' direct or indirect competition across all of the common fundamentals between Adverum Biotechnologies and the related equities. This way, we can detect undervalued stocks with similar characteristics as Adverum Biotechnologies or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Adverum Biotechnologies' fundamental indicators could also be used in its relative valuation, which is a method of valuing Adverum Biotechnologies by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Adverum Biotechnologies to competition |
| Fundamentals | Adverum Biotechnologies | Peer Average |
| Return On Equity | -0.76 | -0.31 |
| Return On Asset | -0.3 | -0.14 |
| Operating Margin | (29.22) % | (5.51) % |
| Current Valuation | 63.14 M | 16.62 B |
| Shares Outstanding | 20.8 M | 571.82 M |
| Shares Owned By Insiders | 11.67 % | 10.09 % |
| Shares Owned By Institutions | 79.15 % | 39.21 % |
| Number Of Shares Shorted | 1.53 M | 4.71 M |
| Price To Earning | (2.10) X | 28.72 X |
| Price To Book | 0.99 X | 9.51 X |
| Price To Sales | 143.12 X | 11.42 X |
| Revenue | 3.6 M | 9.43 B |
| Gross Profit | (81.68 M) | 27.38 B |
| EBITDA | (112.6 M) | 3.9 B |
| Net Income | (117.17 M) | 570.98 M |
| Cash And Equivalents | 235.84 M | 2.7 B |
| Cash Per Share | 2.37 X | 5.01 X |
| Total Debt | 75.04 M | 5.32 B |
| Debt To Equity | 0.43 % | 48.70 % |
| Current Ratio | 8.03 X | 2.16 X |
| Book Value Per Share | 6.93 X | 1.93 K |
| Cash Flow From Operations | (90.9 M) | 971.22 M |
| Short Ratio | 9.27 X | 4.00 X |
| Earnings Per Share | (5.95) X | 3.12 X |
| Target Price | 29.71 | |
| Number Of Employees | 121 | 18.84 K |
| Beta | 1.01 | -0.15 |
| Market Capitalization | 143.12 M | 19.03 B |
| Total Asset | 173.01 M | 29.47 B |
| Retained Earnings | (919.78 M) | 9.33 B |
| Working Capital | 77.86 M | 1.48 B |
| Current Asset | 260.99 M | 9.34 B |
| Current Liabilities | 6.57 M | 7.9 B |
Note: Acquisition by Soparkar Peter of 450000 shares of Adverum Biotechnologies at 1.99 subject to Rule 16b-3 [view details]
Adverum Biotechnologies Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Adverum . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Adverum Biotechnologies Buy or Sell Advice
When is the right time to buy or sell Adverum Biotechnologies? Buying financial instruments such as Adverum Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Adverum Biotechnologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Marijuana Thematic Idea Now
Marijuana
Small and mid-cap equities that are involved in production and delivery of Marijuana products. This theme is designed for investors that are willing to accept higher levels of market risk inherited by Marijuana production in the United States. The Marijuana theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marijuana Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Adverum Biotechnologies Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.95) | Revenue Per Share 0.059 | Quarterly Revenue Growth (0.70) | Return On Assets (0.30) | Return On Equity (0.76) |
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.